@article{mbs:/content/journal/jgv/10.1099/vir.0.026187-0, author = "Jackson, David and Elderfield, Ruth A. and Barclay, Wendy S.", title = "Molecular studies of influenza B virus in the reverse genetics era", journal= "Journal of General Virology", year = "2011", volume = "92", number = "1", pages = "1-17", doi = "https://doi.org/10.1099/vir.0.026187-0", url = "https://www.microbiologyresearch.org/content/journal/jgv/10.1099/vir.0.026187-0", publisher = "Microbiology Society", issn = "1465-2099", type = "Journal Article", abstract = "Recovery of an infectious virus of defined genetic structure entirely from cDNA and the deduction of information about the virus resulting from phenotypic characterization of the mutant is the process of reverse genetics. This approach has been possible for a number of negative-strand RNA viruses since the recovery of rabies virus in 1994. However, the recovery of recombinant orthomyxoviruses posed a greater challenge due to the segmented nature of the genome. It was not until 1999 that such a system was reported for influenza A viruses, but since that time our knowledge of influenza A virus biology has grown dramatically. Annual influenza epidemics are caused not only by influenza A viruses but also by influenza B viruses. In 2002, two groups reported the successful recovery of influenza B virus entirely from cDNA. This has allowed greater depth of study into the biology of these viruses. This review will highlight the advances made in various areas of influenza B virus biology as a result of the development of reverse genetics techniques for these viruses, including (i) the importance of the non-coding regions of the influenza B virus genome; (ii) the generation of novel vaccine strains; (iii) studies into the mechanisms of drug resistance; (iv) the function(s) of viral proteins, both those analogous to influenza A virus proteins and those unique to influenza B viruses. The information generated by the application of influenza B virus reverse genetics systems will continue to contribute to our improved surveillance and control of human influenza.", }